Trade MiMedx Group Inc - MDXG CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.05 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023457% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001235% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 1 | ||||||||
| Currency | USD | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 6.77 |
| Open | 6.63 |
| 1-Year Change | 4.91% |
| Day's Range | 6.62 - 6.71 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 15, 2025 | 6.77 | 0.12 | 1.80% | 6.65 | 6.82 | 6.63 |
| Apr 14, 2025 | 6.74 | -0.02 | -0.30% | 6.76 | 6.86 | 6.65 |
| Apr 11, 2025 | 6.81 | -0.07 | -1.02% | 6.88 | 6.97 | 6.45 |
| Apr 10, 2025 | 6.84 | -0.07 | -1.01% | 6.91 | 7.10 | 6.71 |
| Apr 9, 2025 | 7.12 | 0.48 | 7.23% | 6.64 | 7.31 | 6.64 |
| Apr 8, 2025 | 6.86 | -0.25 | -3.52% | 7.11 | 7.20 | 6.75 |
| Apr 7, 2025 | 7.05 | 0.29 | 4.29% | 6.76 | 7.28 | 6.64 |
| Apr 4, 2025 | 7.04 | 0.02 | 0.28% | 7.02 | 7.15 | 6.90 |
| Apr 3, 2025 | 7.28 | -0.08 | -1.09% | 7.36 | 7.41 | 7.23 |
| Apr 2, 2025 | 7.65 | 0.37 | 5.08% | 7.28 | 7.72 | 7.28 |
| Apr 1, 2025 | 7.47 | -0.07 | -0.93% | 7.54 | 7.61 | 7.43 |
| Mar 31, 2025 | 7.58 | 0.25 | 3.41% | 7.33 | 7.62 | 7.33 |
| Mar 28, 2025 | 7.51 | -0.12 | -1.57% | 7.63 | 7.68 | 7.46 |
| Mar 27, 2025 | 7.71 | 0.13 | 1.72% | 7.58 | 7.72 | 7.53 |
| Mar 26, 2025 | 7.61 | -0.19 | -2.44% | 7.80 | 7.82 | 7.55 |
| Mar 25, 2025 | 7.87 | -0.08 | -1.01% | 7.95 | 8.05 | 7.83 |
| Mar 24, 2025 | 8.06 | 0.23 | 2.94% | 7.83 | 8.09 | 7.83 |
| Mar 21, 2025 | 7.90 | 0.03 | 0.38% | 7.87 | 7.97 | 7.70 |
| Mar 20, 2025 | 7.94 | 0.03 | 0.38% | 7.91 | 8.11 | 7.91 |
| Mar 19, 2025 | 8.05 | 0.29 | 3.74% | 7.76 | 8.07 | 7.72 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
MiMedx Company profile
About MiMedx Group Inc
MiMedx Group, Inc. is utilizing amniotic tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts for multiple sectors of healthcare. The Company is focused on addressing the needs of patients with acute and chronic non-healing wounds, and a late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The Company’s platform technologies include AmnioFix, EpiFix, EpiCord, AmnioCord and AmnioFill. Its AmnioFix and EpiFix are its tissue allografts derived from the amnion and chorion layers of the human placental membrane. The EpiCord and AmnioCord are tissue allografts derived from umbilical cord tissue. Its AmnioFill is a particulate product comprised of placental connective tissue matrix, derived from the placental disc and placental membranes.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, MiMedx Group Inc revenues increased 4% to $258.6M. Net loss applicable to common stockholders decreased 80% to $16.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Investigation, restatement and related decrease of 94% to $3.8M (expense), Loss on extinguishment of debt decrease from $8.2M (expense) to
Equity composition
Common Stock $.001 Par, 03/11, 100M auth., 64,331,910 issd., less 50,000 shs. in Treas. @ $25K. Insiders own approx. 18.35%.
| Industry: | Bio Medical Devices |
1775 W Oak Commons Court, Ne
MARIETTA
GEORGIA 30062
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com